12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: Beyond balloon angioplasty

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 4, 2014, Pages 555-564

  Marmagkiolis, Konstantinos ^a   Hakeem, Abdul ^b   Choksi, Nishit ^c   Al Hawwas, Malek ^d   Edupuganti, Mohan Mallikarjuna Rao ^b   Leesar, Massoud A ^e   Cilingiroglu, Mehmet ^f  

^a Citizens Memorial Hospital   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Department of Cardiovascular Medicine ^*  (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

^e University of Alabama at Birmingham   (United States)

^f Peripheral Vascular Institute   (United States)

Author keywords

peripheral arterial disease (PAD); peripheral transluminal angioplasty (PTA)

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; BIOMATERIAL; CARDIOVASCULAR AGENT;

ARTICLE; ATHERECTOMY; BALLOON; CARDIOVASCULAR THERAPEUTIC DEVICE; CRYOBALLOON; DIRECTIONAL ATHERECTOMY; DRUG COATED BALLOON; DRUG ELUTING STENT; EXCIMER LASER; FEMOROPOPLITEAL OCCLUSIVE DISEASE; HUMAN; LASER ATHERECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF EXPANDING NITINOL STENT; VASCULAR PATENCY; ADVERSE EFFECTS; CENTRAL VENOUS CATHETER; DEVICES; ENDOVASCULAR SURGERY; FEMORAL ARTERY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS; RECURRENT DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; HUMANS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS DESIGN; RECURRENCE; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84905509095     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25510     Document Type: Article

References (62)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.
2. Kasapis C, Gurm HS,. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 2009; 5: 296-311.
3. Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, et al. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: Results of the 4-EVER trial. J Endovasc Ther 2013; 20: 746-756.
4. Hong SJ, Ko YG, Kim JS, Hong MK, Jang Y, Choi D,. Midterm outcomes of subintimal angioplasty supported by primary proximal stenting for chronic total occlusion of the superficial femoral artery. J Endovasc Ther 2013; 20: 782-791.
5. Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, et al. The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the protege everflex nitinol stent system II (DURABILITY II). J Vasc Surg 2013; 58: 73-83.e1.
6. Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, et al. Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: The SUPER study. Cardiovasc Intervent Radiol 2013; 36: 353-361.
7. Lichtenberg M, Stahlhoff W, Boese D,. Superficial femoral artery TASC D registry: Twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia. J Cardiovasc Surg (Torino) 2013; 54: 433-439.
8. Schulte KL, Kralj I, Gissler HM, Bagnaschino LA, Buschmann I, et al. MISAGO 2: One-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. J Endovasc Ther 2012; 19: 774-784.
9. Diehl SJ, Gerblich F, Jochum S, Huck K, Keese M, et al. Twelve-month results of the EverFlex stent in the superficial femoral artery. J Vasc Interv Radiol 2012; 23: 1317-1322.
10. Davaine JM, Azema L, Guyomarch B, Chaillou P, Costargent A, et al. One-year clinical outcome after primary stenting for trans-atlantic inter-society consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artere femorale superficielle" cohort). Eur J Vasc Endovasc Surg 2012; 44: 432-441.
11. Misselt AJ, Zielinski MD, Medina OI, Oderich G, Bjarnason H, et al. Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: Midterm analysis. Angiology 2012; 63: 259-265.
12. Hu H, Zhang H, He Y, Jin W, Tian L, et al. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: A single-center, mid-term result. Ann Vasc Surg 2011; 25: 210-216.
13. Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, et al. Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 2011; 54: 1042-1050.
14. Lagana D, Carrafiello G, Barresi M, Lumia D, Dizonno M, et al. "Full metal jacket" with direct stenting of complete chronic occlusions of the superficial femoral artery. Radiol Med 2011; 116: 444-453.
15. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
16. Bosiers M, Torsello G, Gissler HM, Ruef J, Muller-Hulsbeck S, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-Month results of the DURABILITY I study. J Endovasc Ther 2009; 16: 261-269.
17. Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG,. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg 2009; 50: 542-547.
18. Nishibe T, Kondo Y, Nishibe M, Muto A, Dardik A,. Stent placement for superficial femoral arterial occlusive disease in high-risk patients: Preliminary results. Surg Today 2009; 39: 21-26.
19. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090-1095.
20. Ruef J,. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery. Angiology 2009; 60: 31-35.
21. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML,. Stenting vs. above knee polytetrafluoroethylene bypass for transatlantic inter-society consensus-II C and D superficial femoral artery disease. J Vasc Surg 2008; 48: 1166-1174.
22. Lagana D, Carrafiello G, Dizonno M, Barresi M, Caronno R, et al. Percutaneous treatment of complete chronic occlusions of the superficial femoral artery. Radiol Med 2008; 113: 567-577.
23. Zeller T, Tiefenbacher C, Steinkamp HJ, Langhoff R, Wittenberg G, et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: The femoral artery conformexx trial (FACT). J Endovasc Ther 2008; 15: 390-398.
24. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
25. Ferreira M, Lanziotti L, Monteiro M, Abuhadba G, Capotorto LF, et al. Superficial femoral artery recanalization with self-expanding nitinol stents: Long-term follow-up results. Eur J Vasc Endovasc Surg 2007; 34: 702-708.
26. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
27. Abahji TN, Tato F, Rieger J, Offner A, Will S, et al. Stenting of the superficial femoral artery after suboptimal balloon angioplasty: One-year results. Int Angiol 2006; 25: 184-189.
28. Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: The randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol 2013; 62: 1320-1327.
29. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM,. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013; 58: 386-395.e4.
30. Saxon RR, Chervu A, Jones PA, Bajwa TK, Gable DR, et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-Year results of the VIPER (Viabahn endoprosthesis with heparin bioactive surface in the treatment of superficial femoral artery obstructive disease) trial. J Vasc Interv Radiol 2013; 24: 165-173; quiz 74.
31. Lensvelt MM, Fritschy WM, van Oostayen JA, Holewijn S, Zeebregts CJ, Reijnen MM,. Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease. J Vasc Surg 2012; 56: 118-125.
32. Schneider JR, Verta MJ, Alonzo MJ, Hahn D, Patel NH, Kim S,. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg 2011; 45: 391-397.
33. McQuade K, Gable D, Pearl G, Theune B, Black S,. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010; 52: 584-590; discussion 90-91, 91 e1-91 e7.
34. Kougias P, Chen A, Cagiannos C, Bechara CF, Huynh TT, Lin PH,. Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion. Am J Surg 2009; 198: 645-649.
35. Farraj N, Srivastava A, Pershad A,. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol 2009; 21: 278-281.
36. Lepantalo M, Laurila K, Roth WD, Rossi P, Lavonen J, et al. PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial. Eur J Vasc Endovasc Surg 2009; 37: 578-584.
37. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ,. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-832.
38. Alimi YS, Hakam Z, Hartung O, Boufi M, Barthelemy P, et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: Which factors influence long-term patency? Eur J Vasc Endovasc Surg 2008; 35: 346-352.
39. Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, et al. Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg 2007; 45: 32-39.
40. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D,. Randomized comparison of percutaneous Viabahn stent grafts vs. prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007; 45: 10-16; discussion 16.
41. Fischer M, Schwabe C, Schulte KL,. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 Years of experience. J Endovasc Ther 2006; 13: 281-290.
42. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011; 18: 613-623.
43. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011; 54: 394-401.
44. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther 2006; 13: 701-710.
45. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G,. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: A single-center, prospective, randomized study. J Endovasc Ther 2013; 20: 805-814.
46. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012; 60: 1739-1742.
47. Micari A, Cioppa A, Vadala G, Castriota F, Liso A, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-Month results from a multicenter Italian registry. JACC Cardiovasc Interv 2012; 5: 331-338.
48. Banerjee S, Brilakis ES, Das TS, Lichtenwalter CS,. Treatment of complex superficial femoral artery lesions with PolarCath cryoplasty. Am J Cardiol 2009; 104: 447-449.
49. Bakken AM, Saad WE, Davies MG,. Cryoballoon angioplasty broadens the role of primary angioplasty and reduces adjuvant stenting in complex superficial femoral artery lesions. J Am Coll Surg 2008; 206: 524-532.
50. Samson RH, Showalter DP, Lepore M Jr, Nair DG, Merigliano K,. CryoPlasty therapy of the superficial femoral and popliteal arteries: A reappraisal after 44 months' experience. J Vasc Surg 2008; 48: 634-637.
51. Wissgott C, Kamusella P, Ludtke C, Andresen R,. Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries. J Cardiovasc Surg (Torino) 2013; 54: 359-365.
52. Kim JH, Ahanchi SS, Panneton JM,. Identifying the target lesions for 245 laser angioplasty cases and a review of the literature. Vasc Endovascular Surg 2012; 46: 640-647.
53. Dave RM, Patlola R, Kollmeyer K, Bunch F, Weinstock BS, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: Results of the CELLO registry. J Endovasc Ther 2009; 16: 665-675.
54. Minko P, Katoh M, Jaeger S, Buecker A,. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol 2011; 22: 995-1000.
55. Trentmann J, Charalambous N, Djawanscher M, Schafer J, Jahnke T,. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino) 2010; 51: 551-560.
56. Sixt S, Rastan A, Beschorner U, Noory E, Schwarzwalder U, et al. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: A single-center experience. Vasa 2010; 39: 229-236.
57. Regine R, Catalano O, De Siero M, Di Costanzo G, Ragozzino A,. Endovascular treatment of femoropopliteal stenoses/occlusions with a SilverHawk directional atherectomy device: Immediate results and 12-month follow-up. Radiol Med 2010; 115: 1208-1218.
58. McKinsey JF, Goldstein L, Khan HU, Graham A, Rezeyat C, et al. Novel treatment of patients with lower extremity ischemia: Use of percutaneous atherectomy in 579 lesions. Ann Surg 2008; 248: 519-528.
59. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006; 48: 1573-1578.
60. Liistro F, Grotti S, Porto I, Angioli P, Ricci L, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: The DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv 2013; 6: 1295-1302.
61. Laird JR Jr, Yeo KK, Rocha-Singh K, Das T, Joye J, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: Twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012; 80: 852-859.
62. Banerjee S, Das TS, Abu-Fadel MS, Dippel EJ, Shammas NW, et al. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: The COBRA trial. J Am Coll Cardiol 2012; 60: 1352-1359.